ArticleJournal of mathematical biology2015
Lie Markov models with purine/pyrimidine symmetry.
Article in Journal of mathematical biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Multivariate trait evolution: models for the evolution of the quantitative geneticEvolution letters · 2025Article
- Data integration in Bayesian phylogenetics.Annual review of statistics and its application · 2023Article
- Phylosymmetric Algebras: Mathematical Properties of a New Tool in Phylogenetics.Bulletin of mathematical biology · 2020Article
- The impracticalities of multiplicatively-closed codon models: a retreat to linear alternatives.Journal of mathematical biology · 2020Article
- Embeddability and rate identifiability of Kimura 2-parameter matrices.Journal of mathematical biology · 2020Article
- Position specificity in the genusFungal systematics and evolution · 2018Article
- Matrix group structure and Markov invariants in the strand symmetric phylogenetic substitution model.Journal of mathematical biology · 2016Article
- A New Hierarchy of Phylogenetic Models Consistent with Heterogeneous Substitution Rates.Systematic biology · 2015Article
- Lie Markov models with purine/pyrimidine symmetry.Journal of mathematical biology · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Continuous-time Markov chains are a standard tool in phylogenetic inference. If homogeneity is assumed, the chain is formulated by specifying time-independent rates of substitutions between states in the chain. In applications, there are usually extra constraints on the rates, depending on the situation. If a model is formulated in this way, it is possible to generalise it and allow for an inhomogeneous process, with time-dependent rates satisfying the same constraints. It is then useful to require that, under some time restrictions, there exists a homogeneous average of this inhomogeneous process within the same model. This leads to the definition of "Lie Markov models" which, as we will show, are precisely the class of models where such an average exists. These models form Lie algebras and hence concepts from Lie group theory are central to their derivation. In this paper, we concentrate on applications to phylogenetics and nucleotide evolution, and derive the complete hierarchy of Lie Markov models that respect the grouping of nucleotides into purines and pyrimidines-that is, models with purine/pyrimidine symmetry. We also discuss how to handle the subtleties of applying Lie group methods, most naturally defined over the complex field, to the stochastic case of a Markov process, where parameter values are restricted to be real and positive. In particular, we explore the geometric embedding of the cone of stochastic rate matrices within the ambient space of the associated complex Lie algebra.
Indexed as
Identifiers
24723068What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.